These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 10604987

  • 21. Female agammaglobulinemia due to the Bruton tyrosine kinase deficiency caused by extremely skewed X-chromosome inactivation.
    Takada H, Kanegane H, Nomura A, Yamamoto K, Ihara K, Takahashi Y, Tsukada S, Miyawaki T, Hara T.
    Blood; 2004 Jan 01; 103(1):185-7. PubMed ID: 12958074
    [Abstract] [Full Text] [Related]

  • 22. B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia.
    de Weers M, Brouns GS, Hinshelwood S, Kinnon C, Schuurman RK, Hendriks RW, Borst J.
    J Biol Chem; 1994 Sep 30; 269(39):23857-60. PubMed ID: 7929028
    [Abstract] [Full Text] [Related]

  • 23. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase.
    Khan WN.
    Immunol Res; 2001 Sep 30; 23(2-3):147-56. PubMed ID: 11444380
    [Abstract] [Full Text] [Related]

  • 24. Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk.
    Ellmeier W, Jung S, Sunshine MJ, Hatam F, Xu Y, Baltimore D, Mano H, Littman DR.
    J Exp Med; 2000 Dec 04; 192(11):1611-24. PubMed ID: 11104803
    [Abstract] [Full Text] [Related]

  • 25. Role of Bruton's tyrosine kinase in B cell development.
    Maas A, Hendriks RW.
    Dev Immunol; 2001 Dec 04; 8(3-4):171-81. PubMed ID: 11785667
    [Abstract] [Full Text] [Related]

  • 26. Predominance of sterile immunoglobulin transcripts in a female phenotypically resembling Bruton's agammaglobulinemia.
    de la Morena M, Haire RN, Ohta Y, Nelson RP, Litman RT, Day NK, Good RA, Litman GW.
    Eur J Immunol; 1995 Mar 04; 25(3):809-15. PubMed ID: 7705412
    [Abstract] [Full Text] [Related]

  • 27. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement.
    Petro JB, Rahman SM, Ballard DW, Khan WN.
    J Exp Med; 2000 May 15; 191(10):1745-54. PubMed ID: 10811867
    [Abstract] [Full Text] [Related]

  • 28. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
    Zhu Q, Zhang M, Rawlings DJ, Vihinen M, Hagemann T, Saffran DC, Kwan SP, Nilsson L, Smith CI, Witte ON, Chen SH, Ochs HD.
    J Exp Med; 1994 Aug 01; 180(2):461-70. PubMed ID: 7519238
    [Abstract] [Full Text] [Related]

  • 29. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice.
    Rawlings DJ, Saffran DC, Tsukada S, Largaespada DA, Grimaldi JC, Cohen L, Mohr RN, Bazan JF, Howard M, Copeland NG.
    Science; 1993 Jul 16; 261(5119):358-61. PubMed ID: 8332901
    [Abstract] [Full Text] [Related]

  • 30. Role of Bruton's tyrosine kinase in immunodeficiency.
    Tsukada S, Rawlings DJ, Witte ON.
    Curr Opin Immunol; 1994 Aug 16; 6(4):623-30. PubMed ID: 7946052
    [Abstract] [Full Text] [Related]

  • 31. The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes.
    Kim U, Qin XF, Gong S, Stevens S, Luo Y, Nussenzweig M, Roeder RG.
    Nature; 1996 Oct 10; 383(6600):542-7. PubMed ID: 8849728
    [Abstract] [Full Text] [Related]

  • 32. X-linked agammaglobulinemia and other immunoglobulin deficiencies.
    Smith CI, Islam KB, Vorechovský I, Olerup O, Wallin E, Rabbani H, Baskin B, Hammarström L.
    Immunol Rev; 1994 Apr 10; 138():159-83. PubMed ID: 8070814
    [No Abstract] [Full Text] [Related]

  • 33. A mutation in Bruton's tyrosine kinase as a cause of selective anti-polysaccharide antibody deficiency.
    Wood PM, Mayne A, Joyce H, Smith CI, Granoff DM, Kumararatne DS.
    J Pediatr; 2001 Jul 10; 139(1):148-51. PubMed ID: 11445810
    [Abstract] [Full Text] [Related]

  • 34. xid affects events leading to B cell cycle entry.
    Brorson K, Brunswick M, Ezhevsky S, Wei DG, Berg R, Scott D, Stein KE.
    J Immunol; 1997 Jul 01; 159(1):135-43. PubMed ID: 9200448
    [Abstract] [Full Text] [Related]

  • 35. The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective.
    Satterthwaite AB, Witte ON.
    Immunol Rev; 2000 Jun 01; 175():120-7. PubMed ID: 10933597
    [Abstract] [Full Text] [Related]

  • 36. Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype.
    Gaspar HB, Ferrando M, Caragol I, Hernandez M, Bertran JM, De Gracia X, Lester T, Kinnon C, Ashton E, Espanol T.
    Clin Exp Immunol; 2000 May 01; 120(2):346-50. PubMed ID: 10792386
    [Abstract] [Full Text] [Related]

  • 37. Immunodeficiency of alymphoplasia mice (aly/aly) in vivo: structural defect of secondary lymphoid organs and functional B cell defect.
    Karrer U, Althage A, Odermatt B, Hengartner H, Zinkernagel RM.
    Eur J Immunol; 2000 Oct 01; 30(10):2799-807. PubMed ID: 11069060
    [Abstract] [Full Text] [Related]

  • 38. Potential application of gene therapy to X-linked agammaglobulinemia.
    Moreau T, Calmels B, Barlogis V, Michel G, Tonnelle C, Chabannon C.
    Curr Gene Ther; 2007 Aug 01; 7(4):284-94. PubMed ID: 17969561
    [Abstract] [Full Text] [Related]

  • 39. Defective B cell development and function in Btk-deficient mice.
    Khan WN, Alt FW, Gerstein RM, Malynn BA, Larsson I, Rathbun G, Davidson L, Müller S, Kantor AB, Herzenberg LA.
    Immunity; 1995 Sep 01; 3(3):283-99. PubMed ID: 7552994
    [Abstract] [Full Text] [Related]

  • 40. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.
    Brooimans RA, van den Berg AJ, Rijkers GT, Sanders LA, van Amstel JK, Tilanus MG, Grubben MJ, Zegers BJ.
    J Med Genet; 1997 Jun 01; 34(6):484-8. PubMed ID: 9192269
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.